Clinical observation of 125I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma

doi:10.3748/wjg.v3.i1.43

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2793)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

193

HTML

2082

Figures (1-4)

217

Tables (1-3)

301

Sum=2793

Mar 15, 1997 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Research

World J Gastroenterol. Mar 15, 1997; 3(1): 43-46
Published online Mar 15, 1997. doi: 10.3748/wjg.v3.i1.43

Full Size Figure Download Figure

Figure 2 Electron microscope observation of resected specimen ¹²⁵I anti alpha fetoprotein treatment. (Li, male, 27 years old, HCC, admittance No.10206 tumor cross section, necrotic material, capsule intact electron microscope: Degeneration, necrosis of tumor tissue). Dissolution of nucleus. × 7700

Citation: Wu YD, Yang KZ, Zhou DN, Gang YQ, Song XQ, Hu XH, Huang BY. Clinical observation of ¹²⁵I-labeled anti-alpha fetoprotein antibody radioimmunotherapy in hepatocellular carcinoma. World J Gastroenterol 1997; 3(1): 43-46
URL: https://www.wjgnet.com/1007-9327/full/v3/i1/43.htm
DOI: https://dx.doi.org/10.3748/wjg.v3.i1.43